Genitourinary Drugs Market 2027 By Disease, Product | The Insight Partners

Genitourinary Drugs Market to 2027 - Global Analysis and Forecasts by Disease (Genitourinary Cancer, Bladder Cancer, Cervical Cancer, Kidney/Renal Cancer, Ovarian Cancer, Prostate Cancer); Product (Sex Hormones, Urologic, Genitourinary Anti-Infective, Gynecological.)

Report Code: TIPRE00004609 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Genitourinary Drugs are drugs used for the treatment of reproductive organ disorders and excretory system disorders. Genitourinary disorders are referred to medical conditions caused by infections that affects the genital area and urinary system.

MARKET DYNAMICS
The Genitourinary Drugs market is anticipated to grow in the forecast period owing to driving factors such as increasing prevalence of genitourinary diseases, growing disposable incomes, regular improvements and advancements in healthcare infrastructure and increasing numbers of pipeline drugs.

MARKET SCOPE
The "Global Genitourinary Drugs Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Genitourinary Drugs market with detailed market segmentation by Dosage, Route of Administration, Application and geography. The global Genitourinary Drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Genitourinary Drugs market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Genitourinary Drugs market is segmented on the basis of Disease and Product. Based on disease the market is segmented into Genitourinary Cancer, Bladder Cancer, Cervical Cancer, Kidney/Renal Cancer, Ovarian Cancer, and Prostate Cancer. Based on product the market is segmented into Sex Hormones, Urologic, Genitourinary Anti-Infective, and Gynecological.


REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Genitourinary Drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Genitourinary Drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Genitourinary Drugs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Genitourinary Drugs market in these regions.


MARKET PLAYERS

The reports cover key developments in the Genitourinary Drugs Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Genitourinary Drugs Market are anticipated to lucrative growth opportunities in the future with the rising demand for Genitourinary Drugs in the global market. Below mentioned is the list of few companies engaged in the Genitourinary Drugs market.

The report also includes the profiles of key Genitourinary Drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  •  Astellas
  •  Betanis
  •  GlaxoSmithKline
  •  Bayer AG
  •  Merck KGaA
  •  Abbott Laboratories
  •  Merck & Co
  •  Bristol-Myers Squibb Co
  •  Genentech Inc
  •  Hoffman-La Roche Inc
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Genitourinary Drugs Market - By Disease
1.3.2 Genitourinary Drugs Market - By Product
1.3.3 Genitourinary Drugs Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. GENITOURINARY DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. GENITOURINARY DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. GENITOURINARY DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. GENITOURINARY DRUGS - GLOBAL MARKET OVERVIEW
6.2. GENITOURINARY DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. GENITOURINARY DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - DISEASE
7.1. OVERVIEW
7.2. DISEASE MARKET FORECASTS AND ANALYSIS
7.3. GENITOURINARY CANCER
7.3.1. Overview
7.3.2. Genitourinary Cancer Market Forecast and Analysis
7.4. BLADDER CANCER
7.4.1. Overview
7.4.2. Bladder Cancer Market Forecast and Analysis
7.5. CERVICAL CANCER
7.5.1. Overview
7.5.2. Cervical Cancer Market Forecast and Analysis
7.6. KIDNEY/RENAL CANCER
7.6.1. Overview
7.6.2. Kidney/Renal Cancer Market Forecast and Analysis
7.7. OVARIAN CANCER
7.7.1. Overview
7.7.2. Ovarian Cancer Market Forecast and Analysis
7.8. PROSTATE CANCER
7.8.1. Overview
7.8.2. Prostate Cancer Market Forecast and Analysis
8. GENITOURINARY DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
8.1. OVERVIEW
8.2. PRODUCT MARKET FORECASTS AND ANALYSIS
8.3. SEX HORMONES
8.3.1. Overview
8.3.2. Sex Hormones Market Forecast and Analysis
8.4. UROLOGIC
8.4.1. Overview
8.4.2. Urologic Market Forecast and Analysis
8.5. GENITOURINARY ANTI-INFECTIVE
8.5.1. Overview
8.5.2. Genitourinary Anti-Infective Market Forecast and Analysis
8.6. GYNECOLOGICAL.
8.6.1. Overview
8.6.2. Gynecological. Market Forecast and Analysis
9. GENITOURINARY DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Genitourinary Drugs Market Overview
9.1.2 North America Genitourinary Drugs Market Forecasts and Analysis
9.1.3 North America Genitourinary Drugs Market Forecasts and Analysis - By Disease
9.1.4 North America Genitourinary Drugs Market Forecasts and Analysis - By Product
9.1.5 North America Genitourinary Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 United States Genitourinary Drugs Market
9.1.5.1.1 United States Genitourinary Drugs Market by Disease
9.1.5.1.2 United States Genitourinary Drugs Market by Product
9.1.5.2 Canada Genitourinary Drugs Market
9.1.5.2.1 Canada Genitourinary Drugs Market by Disease
9.1.5.2.2 Canada Genitourinary Drugs Market by Product
9.1.5.3 Mexico Genitourinary Drugs Market
9.1.5.3.1 Mexico Genitourinary Drugs Market by Disease
9.1.5.3.2 Mexico Genitourinary Drugs Market by Product
9.1.5.4 US Genitourinary Drugs Market
9.1.5.4.1 US Genitourinary Drugs Market by Disease
9.1.5.4.2 US Genitourinary Drugs Market by Product
9.2. EUROPE
9.2.1 Europe Genitourinary Drugs Market Overview
9.2.2 Europe Genitourinary Drugs Market Forecasts and Analysis
9.2.3 Europe Genitourinary Drugs Market Forecasts and Analysis - By Disease
9.2.4 Europe Genitourinary Drugs Market Forecasts and Analysis - By Product
9.2.5 Europe Genitourinary Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Genitourinary Drugs Market
9.2.5.1.1 Germany Genitourinary Drugs Market by Disease
9.2.5.1.2 Germany Genitourinary Drugs Market by Product
9.2.5.2 France Genitourinary Drugs Market
9.2.5.2.1 France Genitourinary Drugs Market by Disease
9.2.5.2.2 France Genitourinary Drugs Market by Product
9.2.5.3 Italy Genitourinary Drugs Market
9.2.5.3.1 Italy Genitourinary Drugs Market by Disease
9.2.5.3.2 Italy Genitourinary Drugs Market by Product
9.2.5.4 Spain Genitourinary Drugs Market
9.2.5.4.1 Spain Genitourinary Drugs Market by Disease
9.2.5.4.2 Spain Genitourinary Drugs Market by Product
9.2.5.5 United Kingdom Genitourinary Drugs Market
9.2.5.5.1 United Kingdom Genitourinary Drugs Market by Disease
9.2.5.5.2 United Kingdom Genitourinary Drugs Market by Product
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Genitourinary Drugs Market Overview
9.3.2 Asia-Pacific Genitourinary Drugs Market Forecasts and Analysis
9.3.3 Asia-Pacific Genitourinary Drugs Market Forecasts and Analysis - By Disease
9.3.4 Asia-Pacific Genitourinary Drugs Market Forecasts and Analysis - By Product
9.3.5 Asia-Pacific Genitourinary Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Genitourinary Drugs Market
9.3.5.1.1 Australia Genitourinary Drugs Market by Disease
9.3.5.1.2 Australia Genitourinary Drugs Market by Product
9.3.5.2 China Genitourinary Drugs Market
9.3.5.2.1 China Genitourinary Drugs Market by Disease
9.3.5.2.2 China Genitourinary Drugs Market by Product
9.3.5.3 India Genitourinary Drugs Market
9.3.5.3.1 India Genitourinary Drugs Market by Disease
9.3.5.3.2 India Genitourinary Drugs Market by Product
9.3.5.4 Japan Genitourinary Drugs Market
9.3.5.4.1 Japan Genitourinary Drugs Market by Disease
9.3.5.4.2 Japan Genitourinary Drugs Market by Product
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Genitourinary Drugs Market Overview
9.4.2 Middle East and Africa Genitourinary Drugs Market Forecasts and Analysis
9.4.3 Middle East and Africa Genitourinary Drugs Market Forecasts and Analysis - By Disease
9.4.4 Middle East and Africa Genitourinary Drugs Market Forecasts and Analysis - By Product
9.4.5 Middle East and Africa Genitourinary Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Genitourinary Drugs Market
9.4.5.1.1 South Africa Genitourinary Drugs Market by Disease
9.4.5.1.2 South Africa Genitourinary Drugs Market by Product
9.4.5.2 Saudi Arabia Genitourinary Drugs Market
9.4.5.2.1 Saudi Arabia Genitourinary Drugs Market by Disease
9.4.5.2.2 Saudi Arabia Genitourinary Drugs Market by Product
9.4.5.3 U.A.E Genitourinary Drugs Market
9.4.5.3.1 U.A.E Genitourinary Drugs Market by Disease
9.4.5.3.2 U.A.E Genitourinary Drugs Market by Product
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Genitourinary Drugs Market Overview
9.5.2 South and Central America Genitourinary Drugs Market Forecasts and Analysis
9.5.3 South and Central America Genitourinary Drugs Market Forecasts and Analysis - By Disease
9.5.4 South and Central America Genitourinary Drugs Market Forecasts and Analysis - By Product
9.5.5 South and Central America Genitourinary Drugs Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Genitourinary Drugs Market
9.5.5.1.1 Brazil Genitourinary Drugs Market by Disease
9.5.5.1.2 Brazil Genitourinary Drugs Market by Product
9.5.5.2 Argentina Genitourinary Drugs Market
9.5.5.2.1 Argentina Genitourinary Drugs Market by Disease
9.5.5.2.2 Argentina Genitourinary Drugs Market by Product
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. GENITOURINARY DRUGS MARKET, KEY COMPANY PROFILES
11.1. ASTELLAS
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. BETANIS
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. GLAXOSMITHKLINE
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. BAYER AG
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. MERCK KGAA
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. ABBOTT LABORATORIES
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. MERCK AND CO
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. BRISTOL-MYERS SQUIBB CO
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. GENENTECH INC
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. HOFFMAN-LA ROCHE INC
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS

The List of Companies

  1. Astellas
  2. Betanis
  3. GlaxoSmithKline
  4. Bayer AG
  5. Merck KGaA
  6. Abbott Laboratories
  7. Merck & Co
  8. Bristol-Myers Squibb Co
  9. Genentech Inc
  10. Hoffman-La Roche Inc